Intravenous general anesthesia refers to a method in which one or several drugs are injected intravenously and act on the central nervous system through blood circulation to produce general anesthesia. According to different administration methods, intravenous anesthesia can be divided into single administration method, divided administration method and continuous administration method. Due to some limitations of its own, the use of intravenous general anesthesia was once limited. However, since the 1980s, with the continuous improvement of clinical pharmacology research methods, the development of new strong and short-acting intravenous anesthetics and the advent of computerized intravenous automatic drug delivery systems, intravenous anesthesia has been greatly improved. And development, has now become the mainstream general anesthesia solution.
The global Intravenous Injection General Anesthesia Drugs market is projected to grow from US$ 1694 million in 2024 to US$ 2444.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Intravenous Injection General Anesthesia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Intravenous Injection General Anesthesia Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intravenous Injection General Anesthesia Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Intravenous Injection General Anesthesia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Intravenous Injection General Anesthesia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Intravenous Injection General Anesthesia Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
AstraZeneca
Nhwa
Hengrui
Xi'an Libang
Yichang Humanwell
China National Medicines Guorui Pharmaceutical Co.,Ltd.
Maruishi
Lunan Pharmaceutical Group Corporation
Segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segment by Application
Hopitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intravenous Injection General Anesthesia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Injection General Anesthesia Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Intravenous Injection General Anesthesia Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Injection General Anesthesia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Remifentanil
1.2.5 Etomidate
1.2.6 Isoflurane
1.2.7 Other
1.3 Market by Application
1.3.1 Global Intravenous Injection General Anesthesia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hopitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intravenous Injection General Anesthesia Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Region
2.2.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2019-2024)
2.2.3 Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2025-2030)
2.2.4 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Intravenous Injection General Anesthesia Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Intravenous Injection General Anesthesia Drugs Sales by Region
2.4.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region (2019-2024)
2.4.3 Global Intravenous Injection General Anesthesia Drugs Sales by Region (2025-2030)
2.4.4 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intravenous Injection General Anesthesia Drugs Sales by Manufacturers
3.1.1 Global Intravenous Injection General Anesthesia Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous Injection General Anesthesia Drugs in 2023
3.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Manufacturers
3.2.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Intravenous Injection General Anesthesia Drugs Revenue in 2023
3.3 Global Key Players of Intravenous Injection General Anesthesia Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Intravenous Injection General Anesthesia Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Intravenous Injection General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Intravenous Injection General Anesthesia Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intravenous Injection General Anesthesia Drugs Sales by Type
4.1.1 Global Intravenous Injection General Anesthesia Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Intravenous Injection General Anesthesia Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Type
4.2.1 Global Intravenous Injection General Anesthesia Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Intravenous Injection General Anesthesia Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Injection General Anesthesia Drugs Price by Type
4.3.1 Global Intravenous Injection General Anesthesia Drugs Price by Type (2019-2024)
4.3.2 Global Intravenous Injection General Anesthesia Drugs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Intravenous Injection General Anesthesia Drugs Sales by Application
5.1.1 Global Intravenous Injection General Anesthesia Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Intravenous Injection General Anesthesia Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Application
5.2.1 Global Intravenous Injection General Anesthesia Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Intravenous Injection General Anesthesia Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Injection General Anesthesia Drugs Price by Application
5.3.1 Global Intravenous Injection General Anesthesia Drugs Price by Application (2019-2024)
5.3.2 Global Intravenous Injection General Anesthesia Drugs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Intravenous Injection General Anesthesia Drugs Market Size by Type
6.1.1 US & Canada Intravenous Injection General Anesthesia Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Intravenous Injection General Anesthesia Drugs Revenue by Type (2019-2030)
6.2 US & Canada Intravenous Injection General Anesthesia Drugs Market Size by Application
6.2.1 US & Canada Intravenous Injection General Anesthesia Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Intravenous Injection General Anesthesia Drugs Revenue by Application (2019-2030)
6.3 US & Canada Intravenous Injection General Anesthesia Drugs Market Size by Country
6.3.1 US & Canada Intravenous Injection General Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Intravenous Injection General Anesthesia Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Intravenous Injection General Anesthesia Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intravenous Injection General Anesthesia Drugs Market Size by Type
7.1.1 Europe Intravenous Injection General Anesthesia Drugs Sales by Type (2019-2030)
7.1.2 Europe Intravenous Injection General Anesthesia Drugs Revenue by Type (2019-2030)
7.2 Europe Intravenous Injection General Anesthesia Drugs Market Size by Application
7.2.1 Europe Intravenous Injection General Anesthesia Drugs Sales by Application (2019-2030)
7.2.2 Europe Intravenous Injection General Anesthesia Drugs Revenue by Application (2019-2030)
7.3 Europe Intravenous Injection General Anesthesia Drugs Market Size by Country
7.3.1 Europe Intravenous Injection General Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2019-2030)
7.3.3 Europe Intravenous Injection General Anesthesia Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intravenous Injection General Anesthesia Drugs Market Size
8.1.1 China Intravenous Injection General Anesthesia Drugs Sales (2019-2030)
8.1.2 China Intravenous Injection General Anesthesia Drugs Revenue (2019-2030)
8.2 China Intravenous Injection General Anesthesia Drugs Market Size by Application
8.2.1 China Intravenous Injection General Anesthesia Drugs Sales by Application (2019-2030)
8.2.2 China Intravenous Injection General Anesthesia Drugs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Intravenous Injection General Anesthesia Drugs Market Size by Type
9.1.1 Asia Intravenous Injection General Anesthesia Drugs Sales by Type (2019-2030)
9.1.2 Asia Intravenous Injection General Anesthesia Drugs Revenue by Type (2019-2030)
9.2 Asia Intravenous Injection General Anesthesia Drugs Market Size by Application
9.2.1 Asia Intravenous Injection General Anesthesia Drugs Sales by Application (2019-2030)
9.2.2 Asia Intravenous Injection General Anesthesia Drugs Revenue by Application (2019-2030)
9.3 Asia Intravenous Injection General Anesthesia Drugs Sales by Region
9.3.1 Asia Intravenous Injection General Anesthesia Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Intravenous Injection General Anesthesia Drugs Revenue by Region (2019-2030)
9.3.3 Asia Intravenous Injection General Anesthesia Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Intravenous Injection General Anesthesia Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Aspen Pharma
11.1.1 Aspen Pharma Company Information
11.1.2 Aspen Pharma Overview
11.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aspen Pharma Recent Developments
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Company Information
11.2.2 Fresenius-Kabi Overview
11.2.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Fresenius-Kabi Recent Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AbbVie Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Recent Developments
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Company Information
11.4.2 Baxter Healthcare Overview
11.4.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Healthcare Recent Developments
11.5 B.Braun
11.5.1 B.Braun Company Information
11.5.2 B.Braun Overview
11.5.3 B.Braun Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 B.Braun Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B.Braun Recent Developments
11.6 Maruishi
11.6.1 Maruishi Company Information
11.6.2 Maruishi Overview
11.6.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Maruishi Recent Developments
11.7 Piramal
11.7.1 Piramal Company Information
11.7.2 Piramal Overview
11.7.3 Piramal Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Piramal Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Piramal Recent Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Information
11.8.2 Hikma Pharmaceuticals Overview
11.8.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hikma Pharmaceuticals Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Nhwa
11.10.1 Nhwa Company Information
11.10.2 Nhwa Overview
11.10.3 Nhwa Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Nhwa Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nhwa Recent Developments
11.11 Hengrui
11.11.1 Hengrui Company Information
11.11.2 Hengrui Overview
11.11.3 Hengrui Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Hengrui Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hengrui Recent Developments
11.12 Xi'an Libang
11.12.1 Xi'an Libang Company Information
11.12.2 Xi'an Libang Overview
11.12.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Xi'an Libang Recent Developments
11.13 Yichang Humanwell
11.13.1 Yichang Humanwell Company Information
11.13.2 Yichang Humanwell Overview
11.13.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Yichang Humanwell Recent Developments
11.14 China National Medicines Guorui Pharmaceutical Co.,Ltd.
11.14.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
11.14.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Overview
11.14.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
11.15 Maruishi
11.15.1 Maruishi Company Information
11.15.2 Maruishi Overview
11.15.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Maruishi Recent Developments
11.16 Lunan Pharmaceutical Group Corporation
11.16.1 Lunan Pharmaceutical Group Corporation Company Information
11.16.2 Lunan Pharmaceutical Group Corporation Overview
11.16.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Lunan Pharmaceutical Group Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intravenous Injection General Anesthesia Drugs Industry Chain Analysis
12.2 Intravenous Injection General Anesthesia Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravenous Injection General Anesthesia Drugs Production Mode & Process
12.4 Intravenous Injection General Anesthesia Drugs Sales and Marketing
12.4.1 Intravenous Injection General Anesthesia Drugs Sales Channels
12.4.2 Intravenous Injection General Anesthesia Drugs Distributors
12.5 Intravenous Injection General Anesthesia Drugs Customers
13 Market Dynamics
13.1 Intravenous Injection General Anesthesia Drugs Industry Trends
13.2 Intravenous Injection General Anesthesia Drugs Market Drivers
13.3 Intravenous Injection General Anesthesia Drugs Market Challenges
13.4 Intravenous Injection General Anesthesia Drugs Market Restraints
14 Key Findings in The Global Intravenous Injection General Anesthesia Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
AstraZeneca
Nhwa
Hengrui
Xi'an Libang
Yichang Humanwell
China National Medicines Guorui Pharmaceutical Co.,Ltd.
Maruishi
Lunan Pharmaceutical Group Corporation
听
听
*If Applicable.